Select Publications
Journal articles
2020, 'Open trial of Bruton’s tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus', Veterinary Dermatology, 31, pp. 410 - e110, http://dx.doi.org/10.1111/vde.12878
,2020, 'Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris', International Journal of Women's Dermatology, 6, pp. 306 - 310, http://dx.doi.org/10.1016/j.ijwd.2020.03.043
,2020, 'Outcomes and Predictors for Re-stenosis of Esophageal Stricture in Epidermolysis Bullosa: A Multicenter Cohort Study', Journal of Pediatric Gastroenterology and Nutrition, 71, pp. 310 - 314, http://dx.doi.org/10.1097/MPG.0000000000002820
,2020, 'Splicing of the cake can affect the severity of epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 34, pp. 1879 - 1880, http://dx.doi.org/10.1111/jdv.16859
,2020, 'Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)', Journal of the European Academy of Dermatology and Venereology, 34, pp. 1900 - 1913, http://dx.doi.org/10.1111/jdv.16752
,2020, 'Use of face masks in dermatology department during the COVID-19 outbreak', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13521
,2020, 'A systematic review of drug-associated bullous pemphigoid', Acta Dermato-Venereologica, 100, pp. 1 - 9, http://dx.doi.org/10.2340/00015555-3457
,2020, 'Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus', Veterinary Dermatology, 31, pp. 291 - e71, http://dx.doi.org/10.1111/vde.12841
,2020, 'Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-020-01435-3
,2020, 'A dermatologist's perspective of the COVID-19 outbreak', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13538
,2020, 'Atypical Disseminated Variant of Galli-Galli Disease: A Review of the Literature', American Journal of Dermatopathology, 42, pp. 484 - 490, http://dx.doi.org/10.1097/DAD.0000000000001467
,2020, 'Restructuring an academic dermatology practice during the COVID-19 pandemic', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13684
,2020, 'Successful dapsone therapy in inherited epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 34, pp. e333 - e334, http://dx.doi.org/10.1111/jdv.16301
,2020, 'Update on COVID-19 effects in dermatology specialty', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13523
,2020, 'Virtual conferences of dermatology during the COVID-19 pandemic', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13774
,2020, 'Where do we stand as dermatologists in combat with COVID-19', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13638
,2020, 'Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: A phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-020-01419-3
,2020, 'A prickly souvenir from a hedgehog café: tinea manuum secondary to Trichophyton erinacei via international spread', Clinical and Experimental Dermatology, 45, pp. 459 - 461, http://dx.doi.org/10.1111/ced.14111
,2020, 'Biologics and Small Molecules in the Treatment of COVID-19', Journal of drugs in dermatology : JDD, 19, pp. 673 - 675
,2020, 'Multiple milia formation in blistering diseases', International Journal of Women's Dermatology, 6, pp. 199 - 202, http://dx.doi.org/10.1016/j.ijwd.2020.03.045
,2020, 'Reply to: “Biologics for psoriasis during COVID-19 outbreak”', Journal of the American Academy of Dermatology, 82, pp. e219, http://dx.doi.org/10.1016/j.jaad.2020.04.014
,2020, 'Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”', Journal of the American Academy of Dermatology, 82, pp. e215, http://dx.doi.org/10.1016/j.jaad.2020.03.103
,2020, 'The Potential Protective Effect of Estrogen: Why is COVID-19 mortality lower in females than males', International Journal of Women's Dermatology, 6, pp. 152 - 153, http://dx.doi.org/10.1016/j.ijwd.2020.04.011
,2020, 'The response of the Women's Dermatologic Society and the International Journal of Women's Dermatology to the COVID-19 pandemic', International Journal of Women's Dermatology, 6, pp. 129 - 130, http://dx.doi.org/10.1016/j.ijwd.2020.04.008
,2020, 'Treatment considerations for patients with pemphigus during the COVID-19 pandemic', Journal of the American Academy of Dermatology, 82, pp. e235 - e236, http://dx.doi.org/10.1016/j.jaad.2020.04.005
,2020, 'Drug-related adverse effects of vismodegib and sonidegib for locally advanced or metastatic basal cell carcinoma', Australasian Journal of Dermatology, 61, pp. 176 - 177, http://dx.doi.org/10.1111/ajd.13205
,2020, 'Should biologics for psoriasis be interrupted in the era of COVID-19?', Journal of the American Academy of Dermatology, 82, pp. 1217 - 1218, http://dx.doi.org/10.1016/j.jaad.2020.03.031
,2020, 'Diagnosis and management of pemphigus: Recommendations of an international panel of experts', Journal of the American Academy of Dermatology, 82, pp. 575 - 585.e1, http://dx.doi.org/10.1016/j.jaad.2018.02.021
,2020, 'Novel diagnostic method to differentiate antilaminin-332 pemphigoid from other forms of pemphigoid', British Journal of Dermatology, 182, pp. 270 - 271, http://dx.doi.org/10.1111/bjd.18372
,2020, 'The challenges of living with and managing epidermolysis bullosa: Insights from patients and caregivers', Orphanet Journal of Rare Diseases, 15, http://dx.doi.org/10.1186/s13023-019-1279-y
,2020, 'Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus', Journal of Allergy and Clinical Immunology, 145, pp. 173 - 182, http://dx.doi.org/10.1016/j.jaci.2019.08.013
,2020, 'Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus', Journal of the European Academy of Dermatology and Venereology, 34, pp. 153 - 160, http://dx.doi.org/10.1111/jdv.15770
,2020, '12871 A systematic review of drug-induced pemphigoid', Journal of the American Academy of Dermatology, 83, pp. AB113 - AB113, http://dx.doi.org/10.1016/j.jaad.2020.06.539
,2020, '17891 Quality of life score in Indian patients with epidermolysis bullosa and its correlation with clinical severity assessment scores', Journal of the American Academy of Dermatology, 83, pp. AB202 - AB202, http://dx.doi.org/10.1016/j.jaad.2020.06.896
,2020, '282 Larger wounds in recessive dystrophic epidermolysis bullosa patients associated with worse quality of life: Results of a global cross-sectional survey', Journal of Investigative Dermatology, 140, pp. S34 - S34, http://dx.doi.org/10.1016/j.jid.2020.03.288
,2019, 'Inter-rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients', Journal of the European Academy of Dermatology and Venereology, 33, pp. 2327 - 2333, http://dx.doi.org/10.1111/jdv.15817
,2019, 'Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review', Pediatric Dermatology, 36, pp. 843 - 853, http://dx.doi.org/10.1111/pde.13999
,2019, 'Mycobacterium chelonae infection mimicking demodex folliculitis.', Clin Exp Dermatol, http://dx.doi.org/10.1111/ced.14132
,2019, 'What is novel in the clinical management of pemphigus', Expert Review of Clinical Pharmacology, 12, pp. 973 - 980, http://dx.doi.org/10.1080/17512433.2019.1670059
,2019, 'Patients left behind: Rare dermatologic conditions miss the orphan drug development boom', Journal of the American Academy of Dermatology, 81, pp. 1025 - 1026, http://dx.doi.org/10.1016/j.jaad.2019.03.013
,2019, 'Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review', Experimental Dermatology, 28, pp. 1122 - 1130, http://dx.doi.org/10.1111/exd.13771
,2019, 'Epidermolizis bülloza yaşam kalitesi puanlarının klinik uygulamalarının geliştirilmesi: QOLEB anketinde klinik olarak anlamlı sonuçların tanımlanması', Mucosa, 2, pp. 68 - 75, http://dx.doi.org/10.33204/mucosa.598339
,2019, 'Toxicity of glucocorticosteroids in autoimmune blistering diseases', Mucosa, 2, pp. 59 - 67, http://dx.doi.org/10.33204/mucosa.607952
,2019, 'A chlorhexidine conundrum after an epidural delivery: The difficulty of differentiating between chlorhexidine burns and hypersensitivity reactions', International Journal of Women's Dermatology, 5, pp. 269 - 270, http://dx.doi.org/10.1016/j.ijwd.2019.04.023
,2019, 'Introduction to the clinical images section', International Journal of Women's Dermatology, 5, pp. 213, http://dx.doi.org/10.1016/j.ijwd.2019.06.001
,2019, 'Review of autoimmune blistering diseases: the Pemphigoid diseases', Journal of the European Academy of Dermatology and Venereology, 33, pp. 1685 - 1694, http://dx.doi.org/10.1111/jdv.15679
,2019, 'Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease', Skin Appendage Disorders, 5, pp. 263 - 275, http://dx.doi.org/10.1159/000496836
,2019, 'Assessment of the quality of life of egyptian and tunisian autoimmune bullous diseases' patients using an arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires', Anais Brasileiros de Dermatologia, 94, pp. 399 - 404, http://dx.doi.org/10.1590/abd1806-4841.20197198
,2019, 'Autoimmune bullous diseases during pregnancy: Solving common and uncommon issues', International Journal of Women's Dermatology, 5, pp. 166 - 170, http://dx.doi.org/10.1016/j.ijwd.2019.01.003
,2019, 'Cutaneous leishmaniasis: A neglected disfiguring disease for women', International Journal of Women's Dermatology, 5, pp. 158 - 165, http://dx.doi.org/10.1016/j.ijwd.2019.01.002
,